Focus of the Week

January 17, 2020
Rising drug costs in the US is a pressing concern not only for patients who need to receive those drugs, but for employers. The Employers’ Prescription for Affordable Drugs is a coalition that aims to tackle this problem by working with policymakers and stakeholders to encourage and facilitate more transparency, competition, and value into the healthcare system.
 
January 16, 2020
Sickle cell disease is the most common red blood cell disorder in the United States, having been diagnosed in approximately 100,000 African Americans alone. The lack of oxygen from sickle cell buildup can lead to acute pain crises, joint and organ damage, stroke, and reduced life expectancy.
January 15, 2020
In the evolving treatment landscape for sickle cell disease, current standards of treatment involve 4 drugs that have been FDA approved, with further innovations and limitations adding to the paradigm of care.
January 14, 2020
The median time to first intravenous therapy for acute heart failure (AHF) is 3.0 hours in North America compared with 1.2 hours in all other regions, in the International Registry to Assess Medical Practice with Longitudinal Observation for Treatment of Heart Failure. Treatment timing and differences may affect outcomes in patients with AHF.
January 13, 2020
Avalere Health broadcasted its annual Healthcare Industry Outlook for 2020 on January 9. The hour-long discussion included insights on some of the top healthcare topics predicted to have an impact in 2020. Although Medicare and drug pricing took center stage, artificial intelligence, the future of the Affordable Care Act, and 2020 presidential campaign platforms were among the subjects discussed.
January 10, 2020
The authors calculate that Medicaid expansion saved up to 8100 lives between 2014 and 2016, as the Affordable Care Act (ACA) took full effect.
January 09, 2020
Hospitalizations due to heart failure (HF) were associated with a risk for kidney failure (KF) that was 11.4-times greater compared with patients who did not have cardiovascular disease (CVD). Among a group of CVDs that also included atrial fibrillation, coronary heart disease, and stroke, HF was associated with the highest risk of developing subsequent KF.
 
January 08, 2020
In a poll of people with Parkinson disease, more than 1 in 4 (26%) participants reported having been misdiagnosed, with a further 21% having to see their general provider 3 times before being referred to a specialist.
January 07, 2020
A JAMA study covering data from more than 250,000 women found no statistically significant link between the use of powder in the genital area and risk of ovarian cancer among women. This study comes as public outcry has led to scrutiny of one of the nation’s leading talc powder producers, Johnson & Johnson.
January 06, 2020
Unnecessary testing may expose young women to “preventable harms,” including anxiety, false-positives, and treatment that isn’t needed, according to findings in JAMA Internal Medicine.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.